AU3613984A - New galenic forms of sulpiride which may be orally administered - Google Patents

New galenic forms of sulpiride which may be orally administered

Info

Publication number
AU3613984A
AU3613984A AU36139/84A AU3613984A AU3613984A AU 3613984 A AU3613984 A AU 3613984A AU 36139/84 A AU36139/84 A AU 36139/84A AU 3613984 A AU3613984 A AU 3613984A AU 3613984 A AU3613984 A AU 3613984A
Authority
AU
Australia
Prior art keywords
sulpiride
orally administered
galenic forms
new galenic
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36139/84A
Inventor
Patrice Debregeas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of AU3613984A publication Critical patent/AU3613984A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)

Abstract

Galenic forms of sulpiride comprising microgranules consisting of a neutral grain to which is applied the sulpiride, and an outer layer of microporous polymers, particularly a mixture of methacrylates of the Endragit <R> type. The release in vitro in gastric and artificial intestinal media shows a particular kinetics of those microgranules (see sole figure). A method for the preparation of those forms is disclosed.
AU36139/84A 1983-11-14 1984-11-13 New galenic forms of sulpiride which may be orally administered Abandoned AU3613984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR83/18003 1983-11-14
FR8318003A FR2554718B1 (en) 1983-11-14 1983-11-14 NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE

Publications (1)

Publication Number Publication Date
AU3613984A true AU3613984A (en) 1985-06-03

Family

ID=9294045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36139/84A Abandoned AU3613984A (en) 1983-11-14 1984-11-13 New galenic forms of sulpiride which may be orally administered

Country Status (8)

Country Link
EP (1) EP0145558B1 (en)
AT (1) ATE49883T1 (en)
AU (1) AU3613984A (en)
CA (1) CA1226818A (en)
DE (1) DE3481169D1 (en)
FR (1) FR2554718B1 (en)
WO (1) WO1985002114A1 (en)
ZA (1) ZA848894B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602423B1 (en) * 1986-08-08 1989-05-05 Ethypharm Sa PROCESS FOR THE PREPARATION OF A FENOFIBRATE-BASED MEDICINAL PRODUCT, OBTAINED BY THIS PROCESS
DK173505B1 (en) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Process for producing a slow release diltiazem pellet and using pellets thus prepared
DE4332394A1 (en) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Controlled release budesonide pellets and method of making the same
CN1169857A (en) * 1996-07-10 1998-01-14 林东和 Active composition for relaxing intraocular pressure
FR2762213B1 (en) * 1997-04-18 1999-05-14 Synthelabo PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453642A1 (en) * 1979-04-12 1980-11-07 Sanofi Sa Controlled release of ergo-toxin methane sulphonate - from micro-granules coated with anionic and cationic methacrylic! polymers and a plasticiser
FR2454804B1 (en) * 1979-04-26 1986-11-21 Sanofi Sa DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME
SE8003805L (en) * 1980-05-21 1981-11-22 Haessle Ab A PHARMACEUTICAL PREPARATION WITH IMPROVED EMISSION PROPERTY
FR2494112B1 (en) * 1980-11-19 1986-01-10 Laruelle Claude
FR2534139B1 (en) * 1982-10-07 1986-08-29 Laruelle Claude NOVEL GALENIC FORM OF SULPIRIDE, METHOD FOR PREPARING SAME, AND MEDICINAL PRODUCT COMPRISING THIS NEW FORM

Also Published As

Publication number Publication date
WO1985002114A1 (en) 1985-05-23
EP0145558A2 (en) 1985-06-19
ATE49883T1 (en) 1990-02-15
EP0145558A3 (en) 1985-08-07
DE3481169D1 (en) 1990-03-08
CA1226818A (en) 1987-09-15
EP0145558B1 (en) 1990-01-31
FR2554718A1 (en) 1985-05-17
FR2554718B1 (en) 1986-04-04
ZA848894B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
AU565200B2 (en) Derivatives of cis,endo-2-azabicyclo (3,3,0)-octane 3-carboxylic acid
AU6859687A (en) 610062dro (1H) indole-2-carboxylic acid derivatives and processes for their preparation
AU1000288A (en) An apparatus for the oxygenation of blood
AU2043588A (en) Process for the preparation of 1-olefin polymers
AU2915789A (en) Pharmaceutical compositions
AU584273B2 (en) Tricyclo-3-aza-decane-4-carboxylic acid derivatives and processes for their preparation
AU6331886A (en) Procedure for the manufacture of straw briquettes
AU8883191A (en) Method of making granulated l-lysine
AU3613984A (en) New galenic forms of sulpiride which may be orally administered
AU1970388A (en) Process for the preparation of green briquettes
AU8255487A (en) Process for the synthesis of 1-substituted imidazole-5-carboxylic acids and carboxylic acid derivatives
ES8501623A1 (en) Galenic of sulpiride, process for its preparation and medicament comprising it.
AU563822B2 (en) Pharmaceutical composition of piroxicam and 5&#39;-guanylic acid or n-acetyl-l-methionine
AU1903288A (en) Substituted thienoimidazole derivatives, a process for the preparation thereof, pharmaceutical compositions containing them, and the use thereof as inhibitors of gastric acid secretion, as gastroprotectives and as medicaments for intestinal inflammations
ES8502332A1 (en) Galenic forms of sulpiride for oral administration.
AU7465487A (en) Benzimidazole derivatives and their use as gastric acid secretion inhibitors
AU4545289A (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
AU562822B2 (en) Pharmaceutical composition of clotrimazole
AU5853898A (en) Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo{3.3.0}oct-7-yl)-quinolo ne carboxylic acid and naphthyridone carboxylic acid derivatives for treating (helicobacter pylori) infections and the gastroduodenal diseases associated therewith
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
AU5551698A (en) Process for the preparation of salts and esters of clavulanic acid
AU8282187A (en) 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses
IE813100L (en) Naphthyridine derivatives
AU1509388A (en) Substituted quinoxalyl-imidazolidine-2,4-diones, processes for their preparation, their use as medicaments and pharmaceutical preparations
IE873144L (en) Substituted thienoimidazole-toluidine derivatives, a process¹for their preparation, pharmaceutical compositions¹containing them, and their use as inhibitors of gastric acid¹secretion